Adar Berghoff, MD
Dermatology · Atlanta, GANPI 1023080561
Payments from drug & device makers
Across 127 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$523
- Sanofi$330
- AbbVie$280
- Incyte Corporation$249
- E.r. Squibb & Sons, L.L.C.$214
- Sun Pharmaceutical Industries Inc.$184
- plus $927 from 16 others
What the payments were for
- Food & beverage$2,41689%
- Education$29111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 20 | $523 |
| Sanofi | 14 | $330 |
| AbbVie | 16 | $280 |
| Incyte Corporation | 13 | $249 |
| E.r. Squibb & Sons, L.L.C. | 15 | $214 |
| Sun Pharmaceutical Industries Inc. | 9 | $184 |
| UCB, Inc. | 6 | $166 |
| Pfizer | 7 | $157 |
| LEO Pharma Inc. | 2 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| Arcutis Biotherapeutics, Inc. | 4 | $92 |
| Mayne Pharma Commercial LLC | 4 | $54 |
| Novartis | 2 | $41 |
| Dermavant Sciences, Inc. | 2 | $39 |
| Almirall LLC | 2 | $35 |
| Verrica Pharmaceuticals Inc. | 1 | $30 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
| Journey Medical Corporation | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Organon | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$2,707 in reported general payments places this provider in the 35th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $88,550 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 13 | $87,974 |
| Dupixent SyringeDupilumab | 16 | $59,120 |
| Ketoconazole | 110 | $1,720 |
| Tacrolimus | 11 | $1,560 |
| Clobetasol Propionate | 42 | $1,234 |
| Adapalene-Benzoyl PeroxideAdapalene/Benzoyl Peroxide | 12 | $1,191 |
| Triamcinolone Acetonide | 85 | $1,000 |
| Ciclopirox | 26 | $999 |
| Fluocinonide | 23 | $912 |
| Metronidazole | 18 | $801 |
| Fluorouracil | 11 | $718 |
| Clindamycin Phosphate | 22 | $660 |
| Hydrocortisone | 47 | $651 |
| Doxycycline Hyclate | 26 | $587 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Jamie WeismanAtlanta$4.9M
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$722K
- Ron FeldmanAtlanta$483K
- Jack ArbiserAtlanta$453K
- Mack RachalAtlanta$316K
- Tunisia CorneliusAtlanta$210K
- Emily AltmanAtlanta$178K
- Hailey RouhanaAtlanta$157K
- Lauren OrensteinAtlanta$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.